Form 483

Acella Pharmaceuticals, LLC Form 483, 2024-12-18

FDA issued a Form 483 to Acella Pharmaceuticals, LLC on 2024-12-18 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Acella Pharmaceuticals, LLC · Alpharetta, United States · Issued December 18, 2024

Overview

  • 3 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Dec 2024
21 CFR 314.80(c)(2)

Late submission of annual safety reports

Cited by Matthew R Coleman

18 Dec 2024
21 CFR 314.80(c)(2)

Late submission of quarterly safety reports

Cited by Matthew R Coleman

18 Dec 2024
21 CFR 314.81(b)(2)

Timely submission

Cited by Matthew R Coleman

Inspected site

APAcella Pharmaceuticals, LLCAlpharetta, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 314.80(c)(2)Cited across public-safe Form 483 observations2x
21 CFR 314.81(b)(2)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere